If you haven't already added international flavor to your portfolio, now's a good time to start. In this interview, one of our top experts explains why. Read More

Remaining logical when the herd panics is always a good idea when investing, but it’s especially important during pandemic-induced selloffs. Read More

Pfizer is a growth-and-income stock found in many retirement portfolios. But is the competition from biotech "disruptors" getting too hot for this Big Pharma stalwart? Read More